Healthcare Innovation December 3, 2025
Key changes include streamlining quality measures, exploring future rating methodologies, and expanding enrollment options
On November 25, the Centers for Medicare & Medicaid Services (CMS) announced proposed updates to the Medicare Advantage (MA) and Medicare Part D prescription drug programs. According to a press release, the Contract Year (CY) 2027 MA and Part D proposed rule includes key improvements to the Star Ratings system and invites public input on new ways to modernize MA to better serve beneficiaries and taxpayers.
In the proposed rule, CMS suggests improvements to the MA and Part D Star Ratings that would motivate MA and Part D plans to enhance enrollee care. Starting in 2027, CMS plans to simplify the Star Ratings by removing...
Today's Sponsors
Today's Sponsor